Medical/Pharmaceuticals

Signia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise

LYNGE, Denmark, Sept. 5, 2023 /PRNewswire/ -- Hearing aid innovator Signia, part of WS Audiology, today launchesIntegrated Xperience, a breakthrough technology that enables hearing aid wearers to hear all speakers in noisy group conversations clearly. Even when speakers move or the wearer turns t...

2023-09-05 14:00 1248

ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001

*  Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform *  ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data *  ACM is in partnering d...

2023-09-05 14:00 1715

Signia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise

LYNGE, Denmark, Sept. 5, 2023 /PRNewswire/ -- Hearing aid innovator Signia, part of WS Audiology, today launchesIntegrated Xperience, a breakthrough technology that enables hearing aid wearers to hear all speakers in noisy group conversations clearly. Even when speakers move or the wearer turns t...

2023-09-05 14:00 1537

Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare

* The report shows digital health technologies demonstrate value, yet integrating them into care systems remains challenging. Involving healthcare professionals and patients in technology design and development is also critical for patient-centred care.1 * The report surveyed 10 countries, al...

2023-09-05 13:00 4072

First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventional VAD

SUZHOU, China, Sept. 5, 2023 /PRNewswire/ -- Recently, NyokAssist™ was first-in-man (FIM) use, supporting High-risk PCI completed by Dr. Junbo Ge's team from Zhongshan Hospital inShanghai. This successful implementation of HRPCI initially confirmed the safety and effectiveness of NyokAssist™ in ...

2023-09-05 12:53 1544

GCCL to be the first in the industry sector to adopt Lab Information Management System (LIMS)

* The first clinical trial sample analysis provider to adopt LIMS * To provide enhanced quality of pharmacokinetic, pharmacodynamic, and immunogenicity data from bioanalytic testing YONGIN, South Korea, Sept. 4, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, annou...

2023-09-05 09:57 1353

Ascletis to Participate in the Upcoming Morgan Stanley 21st Annual Global Healthcare Conference

HANGZHOU and SHAOXING, China, Sept. 5, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it will participate in the upcoming Morgan Stanley 21st Annual Global Healthcare Conference.John Gargiulo, Chief Business Officer of Ascletis, will join the fireside chat...

2023-09-05 08:10 2043

Game-changing Virtuoso Digital Front Door technology radically rewires healthcare

World-first technology launches to unlock preventative, proactive and predictive healthcare BOSTON, Sept. 4, 2023 /PRNewswire/ -- Global leader in population health, Orion Health, is ushering in the next era of health – moving from institution-centric reactive sick care to people-centered preven...

2023-09-04 21:00 1697

Seegene Unveils 'Open Innovation Program Powered by Seegene' in Partnership with Springer Nature

* The program is a part of the Seegene OneSystemTM business aimed at creating a 'world free from all diseases' * Collaborating with clinical researchers worldwide, Seegene will share its technologies and enable researchers to develop syndromic qPCR assays SEOUL, South Korea, Sept. 4, 2023 /PR...

2023-09-04 21:00 2319

Global Times: China-Africa medical cooperation broadens under BRI

BEIJING, Sept. 4, 2023 /PRNewswire/ -- Tesfaye Hailemicheal and his colleagues have settled in the new headquarters of the Africa Centers for Disease Control and Prevention (Africa CDC) for over six months now. Hailemicheal still finds himself drawn to the meeting room across from his office. Fro...

2023-09-04 08:43 1780

National University Health System Launches World's First Public Hospital's Healthy Longevity Clinic at Alexandra Hospital

SINGAPORE, Sept. 2, 2023 /PRNewswire/ -- The National University Health System (NUHS), NUS Yong Loo Lin School of Medicine andAlexandra Hospital (AH ) have achieved a milestone by unveiling the world's inaugural Healthy Longevity Clinic by public healthcare. Located atSing...

2023-09-02 13:00 3543

The Latest Global Survey from ISAPS Reports a Rise in Aesthetic Surgery Worldwide

Total surgical and non-surgical procedures increased by 11.2%  MOUNT ROYAL, N.J., Sept. 2, 2023 /PRNewswire/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures this week at the ISAPS Olympiad Athens ...

2023-09-02 02:24 3159

ABM Therapeutics Announces First Patient Dosed in Phase I Study of ABM-1310 in patients with BRAF V600 in Relapsed and Drug Resistant Primary Malignant Brain Tumors

SAN DIEGO, Calif. and SHANGHAI, Sept. 1, 2023 /PRNewswire/ -- ABM Therapeutics, a clinical-stage biopharmaceutical company, today announced that the first patient has been successfully dosed in its multicenter Phase I study of ABM-1310 in patients with relapsed and drug resistant primary malignan...

2023-09-02 00:00 3184

Adicon Holdings Limited (9860.HK): Continuous growth in Core Operations, Consistent Profitability Enhancement

HANGZHOU, China, Sept. 1, 2023 /PRNewswire/ -- Adicon Holdings Limited (the "Company" or "Adicon"), one of the largest independent clinical laboratory (ICL) service providers listed on the Stock Exchange ofHong Kong (SEHK), has released its interim results for the first half of 2023. As a leading...

2023-09-01 21:30 5644

Innovac Therapeutics Completes $18 million Series Pre-A Financing To Fund the Development of Its lead Programs and Manufacturing Capabilities

The funding represents a strong endorsement of Innovac's technology, mission and vision from a range of industry Investors BOSTON, SHANGHAI and HANGZHOU, China, Sept. 1, 2023 /PRNewswire/ -- Innovac Therapeutics, an mRNA therapeutics company, today announced the completion of an $18 million Seri...

2023-09-01 20:08 1704

Peijia Medical Announces 2023 Interim Results

HONG KONG , Sept. 1, 2023 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets, today announced financial results for the six months endedJune 30, 2023 ("the period...

2023-09-01 19:00 4598

EDAN Strengthens Its APAC Business Landscape with Thailand Office Launch

BANGKOK, Sept. 1, 2023 /PRNewswire/ -- EDAN Instruments, Inc. (300206.SZ), a healthcare company and medical device manufacturer, joyfully marked the official inauguration of their freshly establishedBangkok branch, Edan Medical (Thailand) Co., Ltd., and featured ...

2023-09-01 08:40 2992

ZEISS advances cataract and corneal refractive surgical care with new workflow innovations

ZEISS to introduce new cataract and corneal refractive workflow enhancements at ESCRS 2023 JENA, Germany and DUBLIN, Calif., Aug. 31, 2023 /PRNewswire/ -- ZEISS Medical Technology will showcase new ophthalmic innovations within the cataract and corneal refractive workflows at theEuropean Society...

2023-08-31 21:00 1987

CANbridge Announces Interim Financial Results and Corporate Updates for the Six Months Ended June 30, 2023

BEIJING and CAMBRIDGE, Mass., Aug. 31, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals, Inc. ("CANbridge," stock code 1228.HK), a global biopharmaceutical company, with a foundation inChina, committed to the research, development and commercialization of transformative therapies for rare diseases...

2023-08-31 15:15 3971

Tycoon Group Announces 2023 Interim Results

The Group's Revenue Hits New Heights Net profit for 1H2023 increased more than 2.8 times YoY Benefited from the Full Resumption of Normal Travel Revenue Continues to Generate Profit in Future Results Highlights * Since the full resumption of normal travel between Hong Kong, Macau and Mainland C...

2023-08-31 13:28 4046
1 ... 158159160161162163164 ... 614